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ABSTRACT 
Oligosaccharyl Transferase (OST) N-glycosylates nascent polypeptides as they 
are being translocated into the endoplasmic reticulum (ER).  Mammalian OST contains 
eight subunits, of which STT3 is believed to be the catalytic one.  There are two isoforms 
of STT3, STT3-A and STT3-B, which have different kinetic and substrate recognition 
properties.  Interestingly, it was found that both isoforms are present in cells from a 
variety of tissues.  However, it is unclear if both are needed for proper functioning of 
OST. RNAi will be used to knockdown expression of one of the isoforms in HEK293 
cells to measure differing effects in N-glycosylation of proteins. 
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BACKGROUND 
Endoplasmic Reticulum 
 The endoplasmic reticulum, abbreviated ER, is a vital component in eukaryotic 
cells.  It has several primary functions, including calcium ion storage, membrane 
integration of proteins, synthesis of steroids and phospholipids, translocation of proteins, 
and folding and modification of proteins.  The ER extends through the cell, from the 
nuclear envelope to the cell membrane, as one continuous membrane system.  The ER is 
divided into smooth and rough domains, in which different processes occur.  These 
different regions are created by localization of certain proteins in specific areas of the ER.  
While there are many proteins that are shared between the smooth ER (SER) and the 
rough ER (RER), those that are involved in translocation and protein processing are 
concentrated in the RER (Voeltz et al., 2002).   
The SER has a different function depending upon cell type, with only one type 
being present in all cell types.  A region called the transitional ER is a form of SER that is 
found in all cells and is involved in packaging proteins for export to the Golgi.  Cell 
specific types of SER are involved in calcium ion storage and secretion in muscle, steroid 
and phospholipids production, or detoxification of hydrophobic substances (Voeltz et al., 
2002).   
The RER is so called because ribosomes localize there as part of the protein 
translocation pathway, causing this region to appear granular.  Once translocated, 
proteins are modified, most often by glycosylation.  This modification is used to aid in 
protein folding and targeting for secretion or retention (Voeltz et al., 2002).   
 
Glycosylation 
 There are two classes of glycosylation, O-glycosylation and N-glycosylation.  
Glycosylation has previously been well characterized as a signal for membrane or 
extracellular proteins.  However, O-glycosylation occurs on proteins that remain in the 
cytoplasm or the nucleus.  Proteins that are O-glycosylated usually have a single N-
acetylglucosamine (GlcNAc) covalently attached to hydroxyl groups on serine or 
threonine residues.  These proteins also tend to be phosphorylated in addition to being O-
glycosylated.  This post-translational modification seems to serve multiple purposes, 
depending on the protein.  It has been implicated in protecting a protein from degradation 
by the proteosome, being recognized in the major histocompatibility complex class I 
antigen presentation pathway, and lymphocyte activation, among others.  It is believed to 
generally serve a regulatory function in cells, similar to that of phosphorylation (Comer et 
al., 2000).   
 The enzyme that catalyzes the O-glycosylation is a uridine diphospho-N-
acetylglucosamine:polypeptide β-N-acetylglucosaminyltransferase or O-GlcNAc 
transferase (OGT).  Studies have indicated that OGT is localized in the cytosol and the 
nucleus.  OGT is essential for viability of embryonic stem cells, signifying that O-
glycosylation is necessary for eukaryotic cellular physiology (Comer et al., 2000).   
 O-glycosylation has an important role in nuclear trafficking, transcription, and 
translation.  OGT O-glycosylates the exposed surfaces of nucleoporins, which control 
active transport of molecules into and out of the nucleus.  Monoclonal antibodies or 
lectins that bind to O-GlcNAc have been shown to block nuclear transport.  Studies have 
been done to determine exact role O-glycosylation plays in nuclear transport.  While it is 
still unclear how O-glysosylation affects nuclear trafficking, there are two major theories 
to explain it.  The first hypothesis is that O-GlcNAc is an alternant nuclear transport 
signal.  Second, O-glycosylation could have a direct role in regulation of the translocation 
pathway (Comer et al., 2000).   
 In addition to nuclear trafficking, O-glycosylation is also important in regulation 
of transcription.  RNA polymerase II, along with transcription factors, are O-
glycosylated.  The C-terminal domain (CTD) of RNA polymerase II is modified, 
inducing a conformational change, which affects interactions with other transcription 
elements.  O-glycosylation may also contribute to controlling turnover of transcription 
factors or aid in the assembly of transcription complexes.  However, its precise role is 
still unclear (Comer et al., 2000).   
 O-glycosylation also affects the regulation of protein translation.  Eukaryotic 
initiation factor 2 (eIF-2) is a vital component of the translation complex that is 
inactivated by phosphorylation.  However, p67 is a protein that, when O-glycosylated, 
associates with eIF-2 and blocks phosphorylation.  When the cell is placed under stress, a 
deglycosylase is activated which removes the O-GlcNAc from p67, allowing inhibition of 
eIF-2 (Comer et al., 2000).   
 The final main function of O-glycosylation is to modify cytoskeletal proteins.  
Proteins that bridge the cytoskeleton to cell membranes are O-glycosylated.  O-GlcNAc 
modification has been implicated in intermediate filament fibrillogenesis (Comer et al., 
2000).   
 While O-glycosylation has a variety of functions related to intracellular 
regulation, the primary roles of N-glycosylation are stabilizing proteins against 
denaturation or proteolysis, increasing solubility, aiding in immune responses, orienting 
proteins in relation to a membrane, granting structural rigidity, regulating turnover, 
adjusting the isoelectric point of proteins, and mediating interactions with pathogens.  N-
glycosylation is a far more common post-translational modification than O-glycosylation, 
as evidenced by the wide variety of functions it serves (Helenius et al., 2004). 
N-glycosylation occurs in the ER, but glycosylated proteins are further modified 
in the Golgi.  Polypeptides and the oligosaccharide that is transferred to the protein are 
synthesized at the ER.  It is also the location where glycans are covalently linked to 
polypeptides and where initial modification of proteins occurs.  After the ER quality 
control mechanisms ensure that the glycoprotein is folded correctly, it is transported to 
the Golgi, where the oligosaccharide is further modified and trimmed.  In many cases, the 
initial oligosaccharide added is partially disassembled and new saccharides are added 
(Helenius et al., 2004). 
Initially, the purpose of assembling one oligosaccharide just to disassemble it and 
place different saccharides on the polypeptide was unclear.  However, it appears that each 
configuration of oligosaccharides on the protein serves a separate function, instead of just 
being an intermediate in the final processing.  The initial oligosaccharide added is 
important for protein folding and quality control.  The partially trimmed oligosaccharide 
is involved in intracellular transport and targeting.  After extensive modification in the 
Golgi, the glycan on the protein serves a role in its function (Helenius et al., 2004). 
N-linked glycans are attached to the nitrogen on side chains of asparagine 
residues and are exposed on the surface of proteins.  Only the first two GlcNAcs form 
interactions with the surface of the protein; the other saccharides are free.  This has 
several important consequences.  First, N-linked glycans can be modified without severe 
effects on the protein.  Second, it allows cells to imprint N-glycans on cell surface 
proteins with markers for use in cell recognition without altering protein function.  N-
linked glycans are regularly used in signaling pathways because they are exposed on the 
surface of proteins, polar, and can be present in multiple copies per protein.  Also, the 
addition or loss of a single saccharide or an alteration of a single bond can dramatically 
affect binding to lectins, causing it to function differently as a signal (Helenius et al., 
2004). 
In the endoplasmic reticulum, the same presynthesized initial oligosaccharide is added to 
proteins.  This core oligosaccharide is highly conserved in eukaryotes and is composed of 
two N-acetylglucosamines, nine mannoses, and three glucoses (Glc3Man9GlcNAc2) 
(Figure 1).  This core oligosaccharide is then modified in the Golgi to the mature form.  
The ER has to synthesize this macromolecule before transferring it to protein.  Each 
individual saccharide is added to the lipid carrier dolichol-pyrophosphate by 
monosaccharyl-transferases in the ER membrane and synthesis occurs on both sides of 
the membrane (Figure 2).  The two GlcNAcs and the first five mannoses are added to the 
dolichol-pyrophosphate before it is flipped into the lumenal side of the ER for further 
assembly.  The translocation across the membrane is catalyzed by an ATP-independent 
bidirectional flippase.  Each enzyme has strong preference for a single substrate, which 
yields a step-wise assembly of the oligosaccharide.  The final glucose residue that is 
placed in the oligosaccharide is needed for efficient recognition by oligosaccharyl 
transferase (OST), which is the enzyme that transfers the dolichol-oligosaccharide to the 
protein (Helenius et al., 2004). 
Figure 1 The N-linked core oligosaccharide. 
The core glycan has 14 saccharides: 3 glucoses 
(triangles), 9 mannoses (circles), and 2 N-
acetylglucosamines. Each saccharide has a letter 
assigned to it, and these are used in the text to 
identify the saccharide (3). There are three 
branches named A, B, and C. The cleavage sites 
of some glycosidases involved in trimming are 
indicated. Residues a-g (shown by bold 
symbols) are added to the glycan on the 
cytosolic surface of the ER-membrane during 
biosynthesis; the rest are added lumenally. The 
blue residues (d, f, g, and l) are involved in the 
interaction of monoglucosylated glycans with 
calnexin and calreticulin. The green residues, 
with the exception of i, are likely to interact with 
EDEM. (Helenius et al., 2004) 
 
 
 
Figure 2 Synthesis of the N-linked core oligosaccharide and its transfer to a polypeptide chain. 
Biosynthesis occurs on both sides of the ER membrane. The yeast loci required for the individual 
biosynthetic steps are indicated. Synthesis starts on the cytoplasmic side where GlcNAc-1-phosphate is 
transferred from UDP-GlcNAc to dolichylpyrophosphate, followed by an additional GlcNAc and five 
mannose residues. The Man5 GlcNAc2 oligosaccharide, thus generated, is translocated (flipped) into the 
lumen of the ER (13). On the lumenal side, the lipid-linked Man5 GlcNAc2 is extended by the addition of 
four mannose and three glucose residues. The enzymes involved differ from most other 
glycosyltransferases in spanning the membrane several times and in being quite hydrophobic (16, 17, 
34179, 180, 181). Unlike the cytosol-oriented glycosyltransferases that initiate core oligosaccharide 
assembly and Golgi-localized glycosyltransferases, these use lipids (dolichol-P-Man and dolichol-P-Glc) as 
saccharide donors. Little is known about the catalytic mechanism of these interesting enzymes. However, 
based on sequence similarity, a common origin has been suggested (182). (Helenius et al., 2004) 
 
Oligosaccharyl Transferase 
OST is an octamer that is a component of the translocon complex.  All nascent 
polypeptides pass through OST, among other factors, upon exiting the translocon and 
entering the ER.  OST recognizes the glycosylation sequence, Asn-X-Ser/Thr, on nascent 
polypeptides and adds the Glc3Man9GlcNAc2 oligosaccharide to the nitrogen on the side 
chain of Asn.  X can not be proline.  The polypeptide remains unfolded as it passes 
through OST, at a rate of five residues per second.  The N-glycosylation reaction requires 
a loop to be formed in the polypeptide so that the hydroxyl groups of the Ser/Thr residues 
can interact with the amide on the Asn sidechain to make it more nucleophilic.  Proline 
prevents formation of this loop, which is why X can not be proline (Helenius et al., 
2004). 
 OST is composed of eight subunits in yeast, Ost1p, Ost2p, Wbp1, Swp1, Stt3p, 
Ost3p/Ost6p, Ost4p, and Ost5p.  Ost1p, Ost2p, Wbp1, Swp1, and Stt3p are essential for 
OST function.  Ost3p and Ost6p are homologues and only one is present in any given 
OST molecule.  There are mammalian homologues for all of the yeast subunits except 
Ost4p and Ost5p.  Ribophorin I, ribophorin II, Ost48, Dad1, STT3-A/STT3-B, and 
N33/IAP are mammalian homologues for OST subunits (Kelleher et al., 2003).   
 It is difficult to determine the exact function of each of the subunits because OST 
is so complex.  However, it is believed that STT3, ribophorin I, and OST48 interact 
directly with the substrate.  STT3 is believed to be the catalytic subunit because different 
isoforms affect kinetics and that a bacterial homologue, PglB, is sufficient for OST 
activity (Helenius et al., 2004). 
  
STT3 
STT3-A and STT3-B are isoforms that confer different kinetic properties to the 
OST complexes that they are a component of.  STT3-A and STT3-B have 59% sequence 
homology, with STT3-B having extensions at the N-terminal and C-terminal ends (Figure 
3).  Both isoforms of STT3 are themselves glycosylated (Figure 4).  OST containing  
 
Figure 3 – STT3 isoform homology 
Sequence identity between signal sequences (horizontal hatch), lumenal segments (gray), TM spans 
(black), and cytosolic loops (diagonal hatch) of STT3-A and STT3-B.  Nonhomologous extensions and an 
insertion in the STT3-B sequence are indicated by alternate hatching relative to STT3-A.  The letters d and 
e designate the region on the polypeptide that antibodies were raised against (Kelleher et al., 2003). 
 
 
Figure 4 – Endo H digestion of STT3 isoforms 
Immunoblot of STT3-A and STT3-B in the absence (-) or presence (+) of Endo H.  The asterisk indicates a 
polypeptide recognized by the secondary antibody (Kelleher et al., 2003).  
 
STT3-A as a subunit has a higher affinity for fully assembled Glc3Man9GlcNAc2 
substrate, but a lower Vm than OST containing STT3-B (Figure 5).  In Figure 5, OST I 
contains STT3-B, OST II contains a mix of both STT3-A and STT3-B, and OST III 
contains STT3-A.  OST I and OST II have a five to six fold higher turnover number than 
OST III when Glc3Man9GlcNAc2- PP- Dol is used as a substrate.  They have a seventeen 
to twenty fold higher turnover number when Man9GlcNAc2- PP-Dol is used as a 
substrate.  It is believed that binding of an oligosaccharide donor to an activator or 
regulatory site is necessary for binding of donor and acceptor substrates to the catalytic 
site.  The Km for the tripeptide acceptor (Kp) in OST I is unaffected by the structure of the 
donor substrate.  However, OST III has a higher affinity for Glc3Man9GlcNAc2- PP- Dol 
than Man9GlcNAc2- PP-Dol.  Figures 5C and 5D show OST activity assays.  When 
Glc3Man9GlcNAc2- PP- Dol is used as a substrate, both OST I and OST III have similar 
 
Figure 5. Kinetic Properties of OST Isoforms 
(A) The activity of OST-I, OST-II, and OST-III was determined in assays that contained 5 µM Nα-Ac-Asn-
[125I]Tyr-Thr-NH2 as the tripeptide acceptor and either Glc3Man9GlcNAc2-PP-Dol (G3; 700 nM or 1 µM), 
Man9GlcNAc2-PP-Dol (M9; 700 nM or 1 µM), or a donor substrate mixture (mix; 100 nM 
Glc3Man9GlcNAc2-PP-Dol plus 1 µM Man9GlcNAc2-PP-Dol). The rate of glycopeptide formation for the 
700 nM and 1 µM assays were averaged to obtain apparent Vmax values, which are expressed as the 
turnover number.(B) The apparent Km for the tripeptide acceptor (Kp) was determined in assays that 
contained 5–90 µM tripeptide acceptor and either 600 nM Glc3Man9GlcNAc2-PP-Dol or 600 nM 
Man9GlcNAc2-PP-Dol.(C and D) Donor substrate saturation curves for assays that contained 2.1 nM OST-I 
or 9 nM OST-III were obtained for Glc3Man9GlcNAc2-PP-Dol (C) or Man9GlcNAc2-PP-Dol (D) in assays 
that contained 5 µM (C) or 10 µM (D) acceptor tripeptide. The Kp values from (B) were used for curve 
fitting. (E) Glycopeptides from selected assays in (A) were resolved by HPLC to separate 
Glc3Man9GlcNAc2-NYT from Man9GlcNAc2-NYT. The HPLC profiles (offset for clarity) are from the 
following assays: (a) OST-II, 1 µM Glc3Man9GlcNAc2-PP-Dol; (b) OST-III, donor mix; (c) OST-II, donor 
mix; (d) OST-I, donor mix; (e) OST-II, 1 µM Man9GlcNAc2-PP-Dol.(F) The HPLC-resolved glycopeptides 
(E) were quantified to calculate the donor preference ratio (DP) using the following equation: DP = (M9-
PP-Dol/G3-PP-Dol) × (G3-P/M9-P). M9-PP-Dol and G3-PP-Dol are the concentrations of the donor 
substrates, and G3-P and M9-P are the quantities, in cpm, of the glycopeptide products (Kelleher et al., 
2003) 
 
activities.  However, when Man9GlcNAc2- PP- Dol is used, the activity of OST III 
significantly decreased, while the activity of OST I increased slightly.  Figure 5F shows 
donor preference ratios for OST I, OST II, and OST III.  OST I prefers the 
Glc3Man9GlcNAc2- PP- Dol only slightly over that of Man9GlcNAc2- PP- Dol.  
However, OST III has a much higher preference for Glc3Man9GlcNAc2- PP- Dol than for 
Man9GlcNAc2- PP- Dol (Kelleher et al., 2003). 
 While there are kinetic differences between OST enzymes containing STT3-A or 
STT3-B, both types are found in a variety of tissues (Figure 6).  Ribophorin I is found in  
 
 
Figure 6. Differential Expression of OST 
Subunits 
(A) Multiple tissue Northern blots were hybridized 
with probes specific for ribophorin I, STT3-A, 
STT3-B, IAP, N33, and β-actin. The hybridization 
positive bands are consistent with the expected 
mRNA sizes for ribophorin I (2.5 kb), STT3-A (2.7 
kb), STT3-B (4.4 kb), IAP (2.2 kb), N33 (1.8 and 
2.1 kb), and β -actin (2.0 kb). The β -actin mRNA 
probe served as a gel loading control.(B) 
Microsomes isolated from canine pancreas (CP), 
human fibroblasts (HF), and CH12.LX cells 
(CH12.LX) were resolved by PAGE in SDS and 
probed with antibodies to STT3-A or STT3-B. The 
amount of CP microsomes loaded per gel lane is 
expressed in eq (400 fmol OST/eq of CP 
microsomes). The quantity of HF and CH12.LX 
microsomes loaded per gel lane is derived from the 
indicated number of cells. Densitometry was used to 
estimate the amount of STT3-A and STT3-B in the 
HF and CH12.LX microsomes relative to the CP 
microsome standard. (Kelleher et al., 2003) 
all OST complexes and, therefore, is an indicator of OST expression.  STT3-A is 
expressed highly in placenta, liver, skeletal muscle, and pancreas.  It is found in lower 
levels in brain, lung, and kidney.  STT3-B is expressed in more even levels in the 
different tissues.  Both isoforms are expressed in human fibroblasts and CH12.LX cells 
as shown in Figure 6B.  Experiments have shown that both STT3-A and STT3-B 
containing OST complexes are present within a single cell type (Kelleher et al., 2003). 
PROJECT PURPOSE 
 The STT3 subunit of oligosaccharyl transferase has been previously characterized 
to have two isoforms, STT3-A and STT3-B.  These different OST isoforms have 
different kinetic and substrate recognition properties.  However, different cell types 
contain both the STT3-A and STT3-B form of OST.  It is unclear why a single cell type 
would contain both isoforms.  The goal of this project was to knockdown expression of 
one isoform of STT3, using RNAi, in order to study the effect that would have on 
glycosylation.  However, due to time constraints, the knockdown was not able to be 
achieved. 
METHODS 
Cell Culture 
 HEK293 cells were grown in DMEM (containing 4.5 g/L glucose and 110 mg/L 
sodium pyruvate and 2 mM L-glutamine), supplemented with 10% (v/v) heat-inactivated 
fetal bovine serum and incubated at 37° C with 5% CO2.   
Preparation of Cell Lysates 
 Cells were lysed using three different techniques.  In the sonication method, cells 
were suspended in sonication buffer composed of: 
50 mM TEA pH 7.5 
0.1 M KOAc 
0.1% Nikkol 
1 mM DTT 
Then, the cells were frozen at -80° C for a minimum of 1 hour, thawed, and sonicated.  
The lysate was then centrifuged and the pellet discarded. 
In the lysis buffer method, cells were suspended in lysis buffer composed of: 
50 mM Tris-HCl pH 7.5 
5 mM EDTA 
1% SDS 
Then, cells were centrifuged and the pellet discarded.  In Dan’s method, cells were 
suspended in Dan’s buffer composed of: 
20 mM Tris-HCl pH 7.5 
0.25 M Sucrose 
50 mM KOAc 
6 mM Mg(OAc)2 
1 mM EDTA 
1 mM DTT 
Then, the cells were frozen at -80° C for a minimum of 1 hour, thawed, and 
homogenized.  The lysate was then centrifuged and the pellet discarded. 
Western Blots 
 Proteins were resolved by SDS-PAGE and transferred to a PVDF membrane.  
Primary antibodies for STT3-A and STT3-B were polyclonal and had been previously 
made in the lab from a rabbit using the C-terminal domain of each isoform as their 
epitopes.  The antibody for LAMP-2 was a monoclonal mouse antibody and was 
purchased from Santa Cruz Biotechnology.  The secondary antibodies used were goat 
anti-rabbit or goat anti-mouse with horseradish peroxidase (HRP) covalently attached.  
Immunoblots were visualized using ECL. 
Protein Quantification 
Protein samples run on SDS-PAGE gels were quantified using two methods.  In 
order to measure equivalents, samples were incubated at room temperature for twenty 
minutes in 1% SDS.  Then, the absorbance of each sample was measured at OD280.  One 
equivalent is 50 OD280 units/mL. 
Proteins were also quantified using the BioRad Protein Quantification Assay. 
PNGase F Digestion 
Samples were incubated with 1 µL of PNGase F at 37° C for 1 hour. 
RESULTS 
 In order to eventually perform the STT3 isoform knockdown experiments, 
preliminary technique development had to be performed first.  An antibody against 
STT3-B had previously been created in the lab, but it had never been tested.  When an 
immunoblot was performed using this polyclonal rabbit antibody, many nonspecific 
bands appeared on the blot.  In order to confirm that the band believed to be STT3-B was 
in fact STT3-B, an immunoblot was run, probing the left half with the STT3-B antibody 
and the right half with an antibody for ribophorin I (RI) (Figure 7).  Liver rough 
microsomes (LRM638) extracted from dog liver were used as a partially purified ER 
membrane sample.  The RI antibody was been characterized previously and, while 
unspecific bands are present, it is known where it migrates on an SDS-PAGE gel.  STT3-
B was projected to migrate just above RI, at ~85 kDa, so its position is confirmed on the 
immunoblot.   
 After confirming that the band recognized by the STT3-B antibody was indeed 
STT3-B, it was necessary to develop a method of cell lysis for both isoforms for further 
study.  Three methods were tested, the first being sonication of the cells.  The cells were 
also placed in Lysis buffer containing a strong detergent or mechanically homogenized 
(see Methods).  HEK293 cells were subjected to each of the three methods of lysis and an 
immunoblot was performed, probing for either STT3 isoform (Figure 8).  The STT3-A 
signal was the strongest in the pellets and the lysis buffer supernatants (Figure 8A).  The 
pellets contained nuclear components, including DNA, so the supernatant samples were 
more desirable to use in further experiments.  The STT3-B signal was more uniformly 
distributed between the different methods in either the supernatant or the pellet.  Since it  
 Figure 7 – Confirmation of STT3-B Detection 
Increasing amounts of equivalents of Liver Rough 
Microsomes (LRM638) from dog liver were run on 
an 8% SDS-PAGE gel.  The blot was probed for 
STT3-B on the left and RI on the right.  The relative 
position of the STT3-B band to the RI band 
confirms that that band is STT3-B. 
 
did not make a significant difference which method was used to lyse cells to detect 
STT3-B, but STT3-A signal was much higher in lysis buffer supernatant, it was decided 
to use the lysis buffer method in further experiments.   
 Once STT3 detection was perfected, a control protein had to be chosen as a 
marker for N-glycosylation when knockdown experiments were performed.  Lysosome 
associated membrane protein 2 (LAMP-2) was chosen because it contains sixteen N-
glycans, making it highly glycosylated (Mane et al., 1989).  Detection of LAMP-2 in 
relation to STT3-A was performed to confirm that migration position of LAMP-2 on a 
gel and to ensure that LAMP-2 is expressed in HEK293 cells normally (Figure 9).  Fully 
glycosylated LAMP-2 is ~100 kDa, so it appears much higher on the gel than STT3-A, 
which is ~60 kDa.  The LRM lanes are negative controls on the LAMP-2 side of the gel.  
LAMP-2 is lost if the purification process of obtaining the LRM samples, so it should not 
be present on an immunoblot. 
 A. B. 
 
 
Figure 8 – HEK293 Cell Lysis Methods 
Three different methods of cell lysis, sonication, lysis buffer, and Dan’s method, were used to determine 
which yielded the highest amount of (A) STT3-A or (B) STT3-B.  Samples were resolved by SDS-PAGE 
on an 8% gel.  The Lysis B. + sup and sup Lysis B. lanes are duplicates. 
 
In order to determine the size of unglycosylated LAMP-2, HEK cell samples were 
digested with PNGase F to remove all N-linked glycans from the protein (Figure 10).  
PNGase F cleaves the bond between the nitrogen atom on the asparagine side chain and 
the first GlcNAc of the oligosaccharide.  Based on the sequence of LAMP-2, the 
unglycosylated form should be ~45 kDa.  However, no signal is detected in the lanes 
digested with PNGase F.  In order to ensure that the PNGase F digestion was working 
properly, half of the immunoblot was probed for STT3-A, which is also glycosylated.  A  
 
 Figure 9 – Detection of LAMP-2 by Immunoblot 
An 8% SDS-PAGE gel was run and probed for 
STT3-A (left) and LAMP-2 (right). 
   
Figure 10 – PNGase F Digestion of HEK Cell Extracts 
Cell extracts were incubated in the presence (+) or 
absence (-) of PNGase F and probed with an antibody for 
STT3-A (left) or LAMP-2 (right). 
 shift in the band for STT3-A was observed when it was digested with PNGase F, 
confirming that the PNGase F digestion worked.   
Since no unglycosylated LAMP-2 signal was detected in the previous experiment, 
it was repeated with addition of extra protease inhibitors (PI) during the PNGase F 
digestion (Figure 11).  It was thought that unglycosylated LAMP-2 may be highly 
unstable and rapidly degraded and that that was the cause of the lack of signal.  Adding 
protease inhibitors to the incubation should be able to stabilize LAMP-2 if it is unstable.  
However, when this experiment was conducted, no specific signal was detected in any 
lane of the immunoblot.  These results are inconclusive since no signal was detected in  
 
Figure 11 – PNGase F Digestion with extra PI 
LRM and HEK samples were incubated in the 
presence (+) or absence (-) of PNGase F with 
extra PI added.   
 
any of the lanes.  The reason for the lack of signal remains unclear and more experiments 
will have to be done to determine the cause. 
DISCUSSION 
 In order to reach the ultimate goal of knockdown of STT3 isoforms using RNAi, 
detection methods of this OST subunit had to be perfected.  It was found that placing the 
cells in lysis buffer with strong detergent to lyse them was the best method of detecting 
both STT3 isoforms in HEK293 cells.   
 LAMP-2 is a protein found in HEK293 cells that is highly glycosylated, with 16 
N-glycans on it surface.  It is desirable to use as a marker for glycosylation in the cell 
because of its larger number of glycosylated sites.  However, detection of the 
unglycosylated form of LAMP-2 has been nonexistent to date.  Since it has been shown 
that the PNGase F was deglycosylating properly, two major theories remain that can 
explain the lack of signal.   
The first hypothesis is that LAMP-2 is unstable and rapidly degraded when it is 
unglycosylated.  The lack of signal on the immunoblots may be due to this degradation of 
the protein, so none is there to be detected.  If this is the case, then adding protease 
inhibitors during the digestion could help stabilize LAMP-2 so that it may be detected.  
An experiment was conducted where extra protease inhibitors were added in the PNGase 
F digestion, but the results were inconclusive.  This experiment would have to be 
repeated in order to conclude if LAMP-2 is unstable when it is deglycosylated. 
The second major theory is that the antibody used against LAMP-2 contains part 
of an oligosaccharide in its epitope.  In this case, the unglycosylated form of the protein is 
present, but not detectable.  The monoclonal LAMP-2 antibody used was purchased from 
Santa Cruz Biotechnology and was raised against adherent spleen cells of human origin.  
If experiments show that addition of protease inhibitors does not result in detection of 
unglycosylated LAMP-2, then a new antibody would have to be obtained to detect it.  
Otherwise, a new marker of glycosylation could be chosen. 
Once a marker protein is able to be properly detected, RNAi experiments will be 
conducted to knockdown one isoform of STT3 and measure its effect on the cell.  In 
order to accomplish this, a plasmid containing DNA that would produce dsRNA would 
be transfected into HEK293 cells.  This dsRNA would have one strand complementary to 
the mRNA of the STT3 isoform that will be knocked down and would activate the post 
transcriptional silencing regulation pathway.   
After knocking down one isoform of STT3, there are two hypotheses as to what 
the results would be.  First, alternative glycosylation of the marker protein could be 
observed, which would indicate that both isoforms are necessary for normal cell function.  
Further studies could then be conducted to determine the interaction of each isoform in 
the N-glycosylation mechanism of the cell.   
Alternatively, no defect in glycosylation could be detected, which would indicate 
that only one isoform is necessary for proper N-glycosylation in the cell.  Further studies 
must be conducted in order to determine the role of each isoform in N-glycosylation of 
proteins in the ER. 
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